HELX
Franklin Genomic Advancements ETF
$30.67
-0.44 (-1.41%)
Currency in USD / Last Updated: 4/15/2024
| Category | Health |
|---|---|
| Market Cap | 9.201M |
| 52 Week High | 32.86 |
| 52 Week Low | 25.36 |
Customize MutualFund.com
Log in or sign up to get started.
Expense Details
| Deferred | 0 |
|---|---|
| 12b-1 | 0 |
| Front Load | 0 |
| Initial Purchase Amount | 0 |
| Redeption Fee | 0 |
| Prospectus | 0.005 |
Overview
| 52 Week High | 32.86 |
|---|---|
| 52 Week Low | 25.36 |
| Market Cap | 9.20M |
| Shares Outstanding | 0.30M |
| Income Dividend Yield | 0.00% |
| Long Term Dividend Yield | 0.00% |
| Short Term Dividend Yield | 0.00% |
| 52 Week Yield (All) | 0.00% |
Returns Annualized
| One Day | -97.25% |
|---|---|
| Five Days | -90.58% |
| One Months | -46.30% |
| Three Months | 8.96% |
| Six Months | 23.27% |
| Nine Months | 0.26% |
| One Year | -1.68% |
| Three Years | -12.35% |
| Five Years | -999 |
| Ten Years | -999 |
| YTD | 2.32% |
| Since Inception | 6.27% |
Returns Total
| One Day | -1.41% |
|---|---|
| Five Days | -4.57% |
| One Month | -4.81% |
| Three Months | 2.17% |
| Six Months | 10.92% |
| Nine Months | 0.20% |
| One Year | -1.67% |
| Three Years | -32.57% |
| Five Years | -999 |
| Ten Years | -999 |
| YTD | 0.66% |
| Since Inception | 28.48% |
Yearly Returns
| 2024 | 0.66% |
|---|---|
| 2023 | 1.13% |
| 2022 | -37.88% |
| 2021 | 9.78% |
| 2020 | 85.07% |
| 2019 | 0.00% |
| 2018 | 0.00% |
| 2017 | 0.00% |
| 2016 | 0.00% |
| 2015 | 0.00% |
Risk against SP-DA
| Alpha | -26.78% |
|---|---|
| Beta | 1.04 |
| Correlation | 70.82% |
| Downside Deviation | 4.38% |
| Coefficient of determination | 50.15% |
| Standard Deviation | 4.98% |
| Sharpe Ratio | -1.51 |
| Sortino | -5.96 |
| Treynor | -6.82 |
| Ulcer Index | 7.17 |
| Ulcer Performance Index | -3.64 |